These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13619675)

  • 21. Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature.
    DUBNICK B; LEESON GA; CHESSIN M; SCOTT CC
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():194-202. PubMed ID: 13818306
    [No Abstract]   [Full Text] [Related]  

  • 22. Intracellular distribution of norepinephrine in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, trans-2-phenylcyclopropylamine and 1-isonicotinyl-2-isopropyl hydrazine.
    GREEN H; SAWYER JL
    J Pharmacol Exp Ther; 1960 Jul; 129():243-9. PubMed ID: 13851489
    [No Abstract]   [Full Text] [Related]  

  • 23. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis and uptake of 5-hydroxytryptamine by the myenteric plexus of the guinea-pig ileum. A histochemical study.
    Robinson RG; Gershon MD
    J Pharmacol Exp Ther; 1971 Aug; 178(2):311-24. PubMed ID: 4398295
    [No Abstract]   [Full Text] [Related]  

  • 25. Could harmaline generate tremor by affecting 5HT release? [proceedings].
    Headley PM; Lodge D
    Br J Pharmacol; 1979 May; 66(1):116P-117P. PubMed ID: 454912
    [No Abstract]   [Full Text] [Related]  

  • 26. Prenatal effects of acute harmaline exposure on fetal brain biogenic amine metabolism.
    Okonmah AD; Brown JW; Blyden GT; Soliman KF
    Pharmacology; 1988; 37(3):203-8. PubMed ID: 2465555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoamine oxidase inhibition and the induction of ponto-geniculo-occipital wave activity by reserpine in the cat.
    Gershon MD; Brooks DC
    J Pharmacol Exp Ther; 1976 Jun; 197(3):556-66. PubMed ID: 6784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of D-amphetamine on rat brain noradrenaline and serotonin.
    MCLEAN JR; MCCARTNEY M
    Proc Soc Exp Biol Med; 1961 May; 107():77-9. PubMed ID: 13774104
    [No Abstract]   [Full Text] [Related]  

  • 29. Neurobiology of tetrahydro-beta-carbolines.
    Buckholtz NS
    Life Sci; 1980 Sep; 27(11):893-903. PubMed ID: 6107810
    [No Abstract]   [Full Text] [Related]  

  • 30. Alterations in the pattern of amine excretion in man produced by a monoamine oxidase inhibitor.
    SJOERDSMA A; LOVENBERG W; OATES JA; CROUT JR; UDENFRIEND S
    Science; 1959 Jul; 130(3369):225. PubMed ID: 13668554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Norepinephrine and 5-hydroxytryptamine contents of hypothalami of rats treated with harmidinehydrochloride.
    Qureshi Z; Akhtar MS; Malik ZA
    Planta Med; 1979 Mar; 35(3):228-34. PubMed ID: 432300
    [No Abstract]   [Full Text] [Related]  

  • 32. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of the opioid analgesic tramadol on inactivation of norepinephrine and serotonin.
    Hennies HH; Friderichs E; Wilsmann K; Floh e L
    Biochem Pharmacol; 1982 Apr; 31(8):1654-5. PubMed ID: 7092957
    [No Abstract]   [Full Text] [Related]  

  • 34. [Histochemical study of the action in vitro of serotonin, of tryptamine and some of their derivatives on rat brain monoamine oxidases].
    Boucaud J; Bouchaud C; Couteaux R
    C R Acad Hebd Seances Acad Sci D; 1967 Jan; 264(5):775-8. PubMed ID: 4989210
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experiences with monoamine oxidase inhibitors and other substances controlling serotonin metabolism].
    CONSBRUCH U; FAUST C
    Psychiatr Neurol (Basel); 1960 Jul; 140():76-82. PubMed ID: 13695106
    [No Abstract]   [Full Text] [Related]  

  • 37. Brain amine concentrations after monoamine oxidase inhibitor administration.
    Jones AB; Pare CM; Nicholson WJ; Price K; Stacey RS
    Br Med J; 1972 Jan; 1(5791):17-9. PubMed ID: 5008339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Various effects of monoamine oxidase inhibitors under conditions of complete monoamine oxidase inhibition on the serotonin, dopamine and noradrenaline levels in the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1966; 17(4):488-97. PubMed ID: 5983631
    [No Abstract]   [Full Text] [Related]  

  • 39. INHIBITION OF MONAMINE OXIDASE BY AN ANTICHOLINESTERASE (DEMECARIUM BROMIDE).
    PANT MC; PARMAR SS; BHARGAVA KP
    Can J Biochem; 1964 Jul; 42():1114-7. PubMed ID: 14209399
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of MAO inhibitors on impeding synaptosomal withdrawal and on dopamine metabolism in rat and human brain].
    Tóthfalusi L; Tekes K; Gaál J; Magyar K
    Acta Pharm Hung; 1989; 59 Suppl 1():75-9. PubMed ID: 2641638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.